Citadel Advisors
PAHC icon

Citadel Advisors’s Phibro Animal Health PAHC Stock Holding History

Citadel Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47,446
Closed -$2.26M – 13883
2025
Q4 		$1.77M Buy
47,446
+13,119
+38% +$533K ﹤0.01% 6168
2025
Q3 		$1.39M Sell
34,327
-133,815
-80% -$4.42M ﹤0.01% 6823
2025
Q2 		$4.29M Buy
+168,142
New +$3.67M ﹤0.01% 4383
2024
Q3 		– Sell
-66,192
Closed -$1.11M – 14952
2024
Q2 		$1.11M Buy
66,192
+35,742
+117% +$574K ﹤0.01% 6375
2024
Q1 		$394K Sell
30,450
-88,699
-74% -$1.06M ﹤0.01% 8894
2023
Q4 		$1.38M Buy
+119,149
New +$1.34M ﹤0.01% 6041
2023
Q3 		– Sell
-10,274
Closed -$141K – 14876
2023
Q2 		$141K Sell
10,274
-39,996
-80% -$573K ﹤0.01% 10423
2023
Q1 		$770K Sell
50,270
-109,764
-69% -$1.68M ﹤0.01% 7370
2022
Q4 		$2.15M Buy
160,034
+88,939
+125% +$1.19M ﹤0.01% 5339
2022
Q3 		$945K Buy
71,095
+31,972
+82% +$552K ﹤0.01% 7112
2022
Q2 		$749K Sell
39,123
-61,075
-61% -$1.16M ﹤0.01% 7694
2022
Q1 		$2M Sell
100,198
-20,051
-17% -$405K ﹤0.01% 6083
2021
Q4 		$2.46M Sell
120,249
-21,836
-15% -$466K ﹤0.01% 5773
2021
Q3 		$3.06M Buy
142,085
+33,909
+31% +$816K ﹤0.01% 5312
2021
Q2 		$3.12M Buy
108,176
+10,493
+11% +$284K ﹤0.01% 5505
2021
Q1 		$2.38M Sell
97,683
-6,457
-6% -$146K ﹤0.01% 5988
2020
Q4 		$2.02M Buy
104,140
+47,907
+85% +$881K ﹤0.01% 5332
2020
Q3 		$978K Buy
56,233
+46,157
+458% +$985K ﹤0.01% 6071
2020
Q2 		$264K Sell
10,076
-67,208
-87% -$1.67M ﹤0.01% 8116
2020
Q1 		$1.87M Sell
77,284
-66,715
-46% -$1.63M ﹤0.01% 4257
2019
Q4 		$3.58M Buy
143,999
+89,074
+162% +$2.07M ﹤0.01% 3544
2019
Q3 		$1.17M Sell
54,925
-41,347
-43% -$1.13M ﹤0.01% 5318
2019
Q2 		$3.06M Sell
96,272
-54,018
-36% -$1.69M ﹤0.01% 3820
2019
Q1 		$4.96M Buy
150,290
+39,540
+36% +$1.23M ﹤0.01% 3009
2018
Q4 		$3.56M Buy
110,750
+22,975
+26% +$867K ﹤0.01% 3289
2018
Q3 		$3.77M Buy
87,775
+72,406
+471% +$3.42M ﹤0.01% 3375
2018
Q2 		$707K Buy
15,369
+4,370
+40% +$193K ﹤0.01% 5810
2018
Q1 		$437K Buy
10,999
+2,254
+26% +$83.5K ﹤0.01% 6128
2017
Q4 		$293K Buy
+8,745
New +$311K ﹤0.01% 6504
2017
Q3 		– Sell
-18,699
Closed -$693K – 7887
2017
Q2 		$693K Buy
18,699
+8,949
+92% +$292K ﹤0.01% 4641
2017
Q1 		$274K Buy
+9,750
New +$275K ﹤0.01% 6008
2016
Q4 		– Sell
-11,573
Closed -$315K – 7682
2016
Q3 		$315K Sell
11,573
-70,907
-86% -$1.6M ﹤0.01% 5599
2016
Q2 		$1.54M Buy
+82,480
New +$1.72M ﹤0.01% 3015
2015
Q4 		– Sell
-6,390
Closed -$202K – 9059
2015
Q3 		$202K Buy
+6,390
New +$233K ﹤0.01% 6140
2015
Q2 		– Sell
-93,801
Closed -$3.32M – 8972
2015
Q1 		$3.32M Buy
93,801
+37,944
+68% +$1.22M ﹤0.01% 2477
2014
Q4 		$1.76M Buy
55,857
+14,530
+35% +$402K ﹤0.01% 3065
2014
Q3 		$926K Buy
41,327
+21,303
+106% +$427K ﹤0.01% 3796
2014
Q2 		$440K Buy
+20,024
New +$381K ﹤0.01% 4564

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Citadel Advisors's PAHC Position: Q1 2026 in Review

Citadel Advisors sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 47,446 shares — an estimated $2.26M sold.

Citadel Advisors first reported a position in PAHC in Q2 2014 and held it in 38 quarters. The position peaked at $4.96M in Q1 2019. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Citadel Advisors reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 47,446 Phibro Animal Health shares in Q1 2026, an estimated $2.26M.
  • Citadel Advisors first reported a position in Phibro Animal Health in Q2 2014 and held it in 38 quarters.
  • Citadel Advisors's Phibro Animal Health position peaked at $4.96M in Q1 2019.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.